Literature DB >> 786522

Chronic mucocutaneous candidiasis accompanied by enhanced antibody production.

K Takeya, K Nomoto, T Matsumoto, T Miyake, K Himeno.   

Abstract

In four cases of chronic mucocutaneous candidiasis (CMCC) enhanced antibody production against candida antigen was detected in association iwth depressed cellular immunity. These patients showed extremely high agglutinin titre to candida antigen, while they were unable to mount delayed hypersensitivity reactions to candida antigen, tuberculin-purified protein derivative (PPD) or to dinitrochlorobenzene (DNCB). They also showed prolonged survival of skin homografts. There was no correlation between migration inhibitory factor (MIF) production and blast transformation in response to candida antigen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 786522      PMCID: PMC1541408     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  7 in total

1.  A study of Candida albicans agglutinins in human sera.

Authors:  H I WINNER
Journal:  J Hyg (Lond)       Date:  1955-12

2.  Chronic mucocutaneous candidiasis: T cell deficiency associated with B cell dysfunction in man.

Authors:  L T Cahill; E Ainbender; P R Glade
Journal:  Cell Immunol       Date:  1974-11       Impact factor: 4.868

3.  Precipitins to Candida albicans in chronic mucocutaneous candidiasis studied by crossed immunoelectrophoresis with intermediate gel. Correlation with clinical and immunological findings.

Authors:  N H Axelsen; C H Kirkpatrick; R H Buckley
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

4.  Immunodeficiencies in chronic muco-cutaneous candidosis.

Authors:  T Lehner; J M Wilton; L Ivanyi
Journal:  Immunology       Date:  1972-05       Impact factor: 7.397

5.  Immune abnormalities associated with chronic mucocutaneous candidiasis.

Authors:  H Valdimarsson; J M Higgs; R S Wells; M Yamamura; J R Hobbs; P J Holt
Journal:  Cell Immunol       Date:  1973-03       Impact factor: 4.868

Review 6.  Chronic mucocutaneous candidiasis: model-building in cellular immunity.

Authors:  C H Kirkpatrick; R R Rich; J E Bennett
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

Review 7.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

  7 in total
  9 in total

Review 1.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 2.  Black yeasts and their filamentous relatives: principles of pathogenesis and host defense.

Authors:  Seyedmojtaba Seyedmousavi; Mihai G Netea; Johan W Mouton; Willem J G Melchers; Paul E Verweij; G Sybren de Hoog
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  Pathological observations in experimental candida infection of sensitized guinea pigs.

Authors:  M Isoda
Journal:  Mycopathologia       Date:  1985-09       Impact factor: 2.574

Review 4.  Cutaneous defenses against dermatophytes and yeasts.

Authors:  D K Wagner; P G Sohnle
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

5.  Immunological observations before and after successful treatment of chronic mucocutaneous candidiasis with ketoconazole and transfer factor.

Authors:  L Corbeel; J L Ceuppens; G Van den Berghe; H Claeys; M Casteels-Van Daele
Journal:  Eur J Pediatr       Date:  1984-11       Impact factor: 3.183

6.  Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.

Authors:  A Fischer; J J Ballet; C Griscelli
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

7.  Cell-mediated immune responses in mice infected with Fonsecaea pedrosoi.

Authors:  N Kurita
Journal:  Mycopathologia       Date:  1979-08-31       Impact factor: 2.574

8.  Enhanced antibody responses induced by Candida albicans in mice.

Authors:  J E Cutler; R K Lloyd
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis.

Authors:  A Durandy; A Fischer; F Le Deist; E Drouhet; C Griscelli
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.